ENvue Medical Overhauls Board Amid Crisis: Two Directors Out, Three New Appointments Including Chairman
FEED is trading near its 52-week low of $0.422 (7.8% above the low) on light trading volume (0.2× avg).
Summary
ENvue Medical announced the resignation of two directors and the appointment of two new directors plus a new Chairman, reshaping its board amid ongoing financial distress and a Nasdaq delisting threat.
Key Events · Executive and Board Changes · FEED
-
Two Directors Resign
On July 14, 2026, David Johnson and Nino Pionati resigned from the Board, with no stated disagreements.
-
New Directors Appointed
Filling the vacancies, Zvi Joseph and Lior Buchman were appointed to the Board and will serve on the Audit Committee and other key committees.
-
New Chairman Named
Consolidating leadership, existing director Prof. Zeev Rotstein was appointed Chairman of the Board.
-
Committee Assignments Shift
Joseph joins the Audit and Nominating/Governance committees; Buchman joins Audit and Compensation, chairing the latter; Rotstein chairs Nominating/Governance.
Analysis · FEED · Industrial Applications And Services
Already grappling with severe financial distress—a going concern warning and a recent Nasdaq delisting notice—ENvue Medical has reshuffled its board. Two directors resigned and were replaced by Zvi Joseph and Lior Buchman, while existing director Prof. Zeev Rotstein was elevated to Chairman. The overhaul signals either a strategic pivot or an attempt to strengthen governance amid the crisis. At a critical time, the new directors bring fresh oversight to audit and compensation committees.
At the time of this filing, FEED was trading at $0.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.8M. The 52-week trading range was $0.42 to $17.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.